Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Emergent Biosolutions Inc. logo

Emergent Biosolutions Inc.

Sector: Healthcare   

Industry: Biotechnology

2.59
 
USD
  
0.15
  
(6.15%)
Optionable: Yes  Market Cap: 127 M  90-day average vol: 3,126,005

Previous close: 2.44  Open: 2.47  Bid: 2.53  Ask: 2.64
52 week range    
1.42   
   13.67
Peers   
MRK / 
SIGA / 
XOMA / 
CMRX / 
GSK / 
PFE / 
CLDX / 
SNGX / 
Last updated: Thursday 28th March 2024
49
MarketXLS Rank
60
Value
46
Technical
42
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

CLDX

1 B-17.331.4

CMRX

1 B-3.15.82

GSK

MRK

0.0356207 B28.877.58

PFE

0.0302298 B15.153.21

SIGA

0 B33.16.43

SNGX

0 B-1.60.6172

TEVA

XOMA

0 B138.120.07
Financials

EBS Income Statement

Annual
Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23
Amortization of intangibles-8 M-7 M-7 M9 M25 M59 M60 M59 M60 M66 M
Basic EPS from continuing operations2.371.561.981.251.065.794.32-4.47-14.85
Basic EPS total0.981.631.291.981.251.065.794.32-4.47-14.85
Basic weighted shares outstanding37 M39 M40 M42 M50 M52 M53 M54 M50 M51 M
BasicDiscontinuousOperations-0.74-0.27
Cost of sales-118 M-107 M-131 M-188 M-322 M434 M392 M758 M693 M705 M
Depreciation-23 M-24 M-28 M-32 M-36 M50 M50 M62 M83 M60 M
Depreciation unreconciled9 M25 M59 M60 M59 M60 M66 M
DepreciationAndAmortization-23 M-24 M-28 M9 M25 M59 M60 M59 M60 M66 M
Diluted EPS total0.881.411.131.711.221.045.674.27-4.47-14.85
Diluted normalized net income/share2.021.351.711.221.045.674.27-4.47-14.85
Diluted weighted shares outstanding46 M47 M49 M50 M51 M52 M54 M54 M50 M51 M
DilutedDiscontinuousOperations-0.61-0.22
GainOnSaleOfBusiness74 M
GainsLossOnDisposalOfDiscontinuedOperations-29 M-11 M
GeneralAndAdministrativeExpense-5 M-3 M-1 M-2 M-3 M274 M303 M348 M340 M368 M
Gross operating profit332 M382 M357 M373 M460 M673 M1,163 M1,035 M424 M344 M
ImpairmentOfCapitalAssets-2 M-11 M42 M7 M218 M
Income before tax53 M136 M99 M119 M82 M77 M407 M314 M-219 M-731 M
Income restructuring and M&A-35 M-12 M-28 M29 M
Income taxes16 M44 M37 M36 M19 M23 M102 M84 M-7 M29 M
Interest income320000.0572000.01 M2 M
InterestExpenseNonOperating8 M7 M8 M7 M10 M38 M31 M35 M37 M88 M
InterestExpenseOperating-7 M-8 M-8 M-7 M
InterestIncomeOperating3 M3 M3 M3 M
MinorityInterests53 M136 M99 M119 M82 M
MiscOtherSpecialCharges3 M153000.0263000.0900000.02 M2 M289 M296 M-7 M15 M
Net income from total operations37 M63 M52 M83 M63 M55 M305 M231 M-212 M-760 M
NetIncomeCommonStockholders37 M63 M52 M83 M63 M55 M305 M231 M-212 M-760 M
NetIncomeContinuousOperations37 M63 M52 M83 M63 M55 M305 M231 M-212 M-760 M
NetIncomeDiscontinuousOperations-29 M-11 M
NetNonOperatingInterestIncomeExpense-8 M-6 M-7 M-7 M-10 M-38 M-31 M-34 M-37 M-88 M
Normalized income-97 M
Operating income58 M142 M106 M124 M90 M114 M434 M353 M-170 M-726 M
Operating income before depreciation (EBITDA)86 M170 M137 M161 M155 M230 M557 M477 M-34 M-497 M
OperatingExpense274 M240 M-383 M-437 M-693 M992 M1,122 M1,440 M1,288 M1,776 M
Other income net-3 M-153000.0-263000.0-900000.0-2 M-2 M-288 M-296 M7 M218 M
OtherGandA-5 M-3 M-1 M-2 M-3 M274 M303 M348 M340 M368 M
OtherImpairmentOfCapitalAssets-10 M-6 M29 M42 M307 M
OtherOperatingExpenses-102000.0-59000.0-299000.0-500000.0-300000.0-1 M-600000.0-5 M-10 M-100000.0
RentAndLandingFees-5 M-3 M-1 M-2 M-3 M
Research & development expense151 M119 M108 M97 M143 M226 M235 M234 M188 M111 M
ResearchExpense151 M119 M108 M97 M143 M226 M235 M234 M188 M111 M
RestructringAndMnAIncome-35 M-12 M-28 M29 M
Revenue per share-7 M-8 M-8 M9 M25 M59 M60 M59 M60 M66 M
SalariesAndWages-13 M-16 M-18 M-15 M-23 M2 M2 M2 M800000.0600000.0
Selling Gen & administrative expense123 M121 M144 M143 M203 M274 M303 M348 M340 M368 M
SellingAndMarketingExpense123 M121 M144 M143 M203 M
SellingExpense123 M121 M144 M143 M203 M
Special income/charges37 M11 M12 M28 M-42 M-7 M-218 M
Total Income available for interest expense (EBIT)54 M134 M99 M118 M91 M116 M439 M349 M-182 M-643 M
Total common shares outstanding38 M41 M49 M51 M52 M53 M51 M50 M52 M
Total net income37 M63 M52 M83 M63 M55 M305 M231 M-212 M-760 M
Total ordinary shares52 M52 M52 M52 M52 M52 M52 M52 M52 M52 M
Total revenues450 M489 M489 M561 M782 M1,106 M1,272 M1,493 M2,079 M1,988 M
TotalExpenses155 M133 M-515 M-624 M-1,015 M1,425 M1,514 M2,198 M1,981 M2,481 M
TotalRevenue312 M329 M296 M561 M782 M1,106 M1,555 M1,793 M1,118 M1,049 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

We respect your privacy and will never share your email.
MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University